Literature DB >> 17493218

Improved pharmacokinetic monitoring of tacrolimus exposure after pediatric renal transplantation.

Martin N Lee1, Lavjay Butani.   

Abstract

Because of its narrow therapeutic index, monitoring of drug exposure is recommended for tacrolimus (T). Limited data are available on kinetics of T in children after transplantation. Our study investigated the correlation between T trough and the area under the time-concentration curve (AUC) in pediatric renal transplant recipients and investigated the effect of steroids. Data on T troughs and two h and four h post-dose concentrations over the first post-transplant year in 20 transplant recipients from August 2001 to June 2005 were analyzed. Patients were analyzed in two groups based on their use of steroids. Although the overall correlation between the troughs and AUC was good (r = 0.85, Pearson test), during the first month the correlation was poor in the cohort receiving steroids (r = 0.5) compared with those on a steroid minimization regimen (r = 0.9). In 85% of patients there was a discrepancy between the trough and AUC leading to errors in dose adjustment. In conclusion, although the overall correlation between T trough and AUC is good, it is suboptimal in the first post-transplant month in children receiving steroids. Because of large variation in exposure, we recommend AUC monitoring for T. Prospective studies are needed to determine the impact of more accurate monitoring of T exposure on outcomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17493218     DOI: 10.1111/j.1399-3046.2006.00618.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  5 in total

1.  Pharmacokinetics of tacrolimus in stable paediatric renal transplant recipients.

Authors:  Tania Claeys; Maria Van Dyck; Rita Van Damme-Lombaerts
Journal:  Pediatr Nephrol       Date:  2009-11-03       Impact factor: 3.714

Review 2.  Therapeutic drug monitoring in pediatric renal transplantation.

Authors:  Lutz T Weber
Journal:  Pediatr Nephrol       Date:  2014-04-25       Impact factor: 3.714

Review 3.  Clinical aspects of tacrolimus use in paediatric renal transplant recipients.

Authors:  Agnieszka Prytuła; Teun van Gelder
Journal:  Pediatr Nephrol       Date:  2018-02-26       Impact factor: 3.714

Review 4.  Drug-metabolizing enzymes CYP3A as a link between tacrolimus and vitamin D in renal transplant recipients: is it relevant in clinical practice?

Authors:  Agnieszka Prytuła; Karlien Cransberg; Ann Raes
Journal:  Pediatr Nephrol       Date:  2018-07-30       Impact factor: 3.714

5.  Conversion from twice- to once-daily tacrolimus in pediatric kidney recipients: a pharmacokinetic and bioequivalence study.

Authors:  Anne-Laure Lapeyraque; Nastya Kassir; Yves Théorêt; Maja Krajinovic; Marie-José Clermont; Catherine Litalien; Véronique Phan
Journal:  Pediatr Nephrol       Date:  2014-01-17       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.